Chang, J.; Lin, S.; Mao, Y.; Xu, Y.; Zhang, Z.; Wu, Q.; Chen, Y.; Wei, Y.; Feng, Q.; Xu, J.
CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy. Cancers 2022, 14, 4646.
https://doi.org/10.3390/cancers14194646
AMA Style
Chang J, Lin S, Mao Y, Xu Y, Zhang Z, Wu Q, Chen Y, Wei Y, Feng Q, Xu J.
CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy. Cancers. 2022; 14(19):4646.
https://doi.org/10.3390/cancers14194646
Chicago/Turabian Style
Chang, Jiang, Songbin Lin, Yihao Mao, Yuqiu Xu, Zhiyuan Zhang, Qi Wu, Yijiao Chen, Ye Wei, Qingyang Feng, and Jianmin Xu.
2022. "CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy" Cancers 14, no. 19: 4646.
https://doi.org/10.3390/cancers14194646
APA Style
Chang, J., Lin, S., Mao, Y., Xu, Y., Zhang, Z., Wu, Q., Chen, Y., Wei, Y., Feng, Q., & Xu, J.
(2022). CXCR6+ Tumor-Associated Macrophages Identify Immunosuppressive Colon Cancer Patients with Poor Prognosis but Favorable Response to Adjuvant Chemotherapy. Cancers, 14(19), 4646.
https://doi.org/10.3390/cancers14194646